research Alopecia universalis. Partial response to tofacitinib
Tofacitinib partially improved hair regrowth in a patient with severe hair loss.
Search
for
Sort by
Research
990-1000 / 1000+ results 
research A Unique Case of Pili Multigemini Complicated by Folliculitis: Unveiling the Intricacies of a Rare Hair-Follicle Disorder
A rare hair disorder with multiple hairs from one follicle was found on a patient's abdomen.
research Growth of Brahman cross heifers grazing Leucaena.
Leucaena was unpalatable, caused health issues, and reduced fertility in heifers.
research Concept and Management of Diffuse Hair Loss (Intithār al-Sha‘r) in the light of Unani medicine: A Review
Unani medicine links diffuse hair loss to poor skin pore function and body dryness, leading to thinning hair.
research La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos
The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.
research Uses, Abundance Perception and Potential Geographical Distribution of Smilax Aristolochiifolia Mill (SMILACACEAE) on the Totonacapan Region of Puebla, Mexico
Smilax aristolochiifolia is less abundant due to environmental changes, but still used in traditional medicine.
research Remarkable Improvement of Nail Changes in Alopecia Areata Universalis with 10 Months of Treatment with Tofacitinib: A Case Report
A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.
research Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.
research Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.